Back to Article List

New specification for steviol glycoside under evaluation by FSANZ

Australia

Aug 24, 2021

FSANZ is evaluating approval of a new specification for the steviol glycoside, rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract. Bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.

For further information (in English), click on the Link

Subscribe to our newsletter

The best industry insight in your mailbox